PARP16 is a Druggable Regulator of Ribosome MARylation and Protein Homeostasis in Ovarian Cancer Cells.
PARP16 is a Druggable Regulator of Ribosome MARylation and Protein Homeostasis in Ovarian Cancer Cells. J Biol Chem. 2026 Sep 08; 113540.
PMID: 42710679
Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.
Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers. Gynecol Oncol. 2026 Sep; 212:134-144.
PMID: 42594534
Uterine organoids reveal insights into epithelial specification and plasticity in development and disease.
Uterine organoids reveal insights into epithelial specification and plasticity in development and disease. Proc Natl Acad Sci U S A. 2025 Feb 04; 122(5):e2422694122.
PMID: 39883834
RACK1 MARylation regulates translation and stress granules in ovarian cancer cells.
RACK1 MARylation regulates translation and stress granules in ovarian cancer cells. J Cell Biol. 2025 Feb 03; 224(2).
PMID: 39760726
Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers.
Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers. Cancers (Basel). 2024 Sep 05; 16(17).
PMID: 39272943
RBN-2397, a PARP7 Inhibitor, Synergizes with Paclitaxel to Inhibit Proliferation and Migration of Ovarian Cancer Cells.
RBN-2397, a PARP7 Inhibitor, Synergizes with Paclitaxel to Inhibit Proliferation and Migration of Ovarian Cancer Cells. bioRxiv. 2024 Sep 05.
PMID: 39229139
A PARP14/TARG1-Regulated RACK1 MARylation Cycle Drives Stress Granule Dynamics in Ovarian Cancer Cells.
A PARP14/TARG1-Regulated RACK1 MARylation Cycle Drives Stress Granule Dynamics in Ovarian Cancer Cells. bioRxiv. 2024 Sep 04.
PMID: 37873085
Detecting Poly (ADP-Ribose) In Vitro and in Cells Using PAR Trackers.
Detecting Poly (ADP-Ribose) In Vitro and in Cells Using PAR Trackers. Methods Mol Biol. 2023; 2609:75-90.
PMID: 36515830
Development and characterization of new tools for detecting poly(ADP-ribose) in vitro and in vivo.
Development and characterization of new tools for detecting poly(ADP-ribose) in vitro and in vivo. Elife. 2022 04 27; 11.
PMID: 35476036
Two birds, one stone: Non-canonical therapeutic effects of the PARP inhibitor Talazoparib.
Two birds, one stone: Non-canonical therapeutic effects of the PARP inhibitor Talazoparib. Cell Chem Biol. 2022 02 17; 29(2):171-173.
PMID: 35180430